BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23769695)

  • 1. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2014 Jul; 89(7):771-9. PubMed ID: 24953862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2012 Dec; 87(12):1096-103. PubMed ID: 23151980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2011 Oct; 86(10):851-8. PubMed ID: 21922525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2016 Jun; 91(4):434-42. PubMed ID: 27001163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Hodgkin lymphoma.
    Ansell SM; Armitage JO
    Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
    Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
    Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2020 Aug; 95(8):978-989. PubMed ID: 32384177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2018 May; 93(5):704-715. PubMed ID: 29634090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2022 Nov; 97(11):1478-1488. PubMed ID: 36215668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin Lymphoma: Diagnosis and Treatment.
    Ansell SM
    Mayo Clin Proc; 2015 Nov; 90(11):1574-83. PubMed ID: 26541251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin lymphoma.
    Gobbi PG; Ferreri AJ; Ponzoni M; Levis A
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):216-37. PubMed ID: 22867814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
    Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
    J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.